Omeprazole and peptic ulcer

NEW YORK, August 3 (Praxis Press) Endoscopic treatments, such as epinephrine injections and thermocoagulation, are widely used to treat bleeding peptic ulcers, but bleeding recurs in 15 to 20% of these patients. To test whether omeprazole would reduce the recurrence of peptic ulcer bleeding, Lau and colleagues randomized 240 patients whose bleeding had been controlled endoscopically to receive either an intravenous infusion of high-dose omeprazole or a placebo for three days after treatment. The

August 8, 2000

NEW YORK, August 3 (Praxis Press) Endoscopic treatments, such as epinephrine injections and thermocoagulation, are widely used to treat bleeding peptic ulcers, but bleeding recurs in 15 to 20% of these patients. To test whether omeprazole would reduce the recurrence of peptic ulcer bleeding, Lau and colleagues randomized 240 patients whose bleeding had been controlled endoscopically to receive either an intravenous infusion of high-dose omeprazole or a placebo for three days after treatment. They found that bleeding recurred in 6.7% of the patients in the omeprazole group as compared with 22.5% in the placebo group. Omeprazole infusion substantially reduced the risk of recurrent bleeding in patients receiving endoscopic treatments for bleeding peptic ulcers.

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham